US EditionTranscend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
UNITED STATES, JUL 10 – TSND-201 showed rapid, durable PTSD symptom improvements in a Phase 2 trial of 65 patients, addressing the limited efficacy of current FDA-approved treatments, FDA said.
Summary by PR Newswire
4 Articles
4 Articles
Transcend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
/PRNewswire/ -- Transcend Therapeutics, a clinical-stage biotechnology company that develops medicines to treat neuropsychiatric diseases, today announced that...
·United States
Read Full Article
PTSD Awareness - WHIZ - Fox 5 / Marquee Broadcasting
ZANESVILLE, Ohio – Post Traumatic Stress Disorder, commonly referred to as PTSD is often associated with military veterans but is a human condition that can affect anyone. Acute Nursing Care Administrator and Registered Nurse Shelly Long explained how PTSD is oftentimes an unexpected natural response that has been triggered by the memory of a negative or stressful, previous experience. “So PTSD is a mental health condition that occurs in anyb…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
